Abstract
It is estimated that in the next decade, dementia and movement disorders will become the second ranking cause of death after cardiovascular disease (1). Dementias and movement disorders are clinically and biologically overlapping manifestations of neurodegenerative disorders. Important areas of overlap are: (i) the spectrum of Alzheimer’s disease (AD), Parkinson’s disease (PD), dementia with Lewy bodies (DLB) (see Table 1); (ii) the spectrum of Pick’s disease (PiD), frontotemporal dementia (FTD), corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), amyotrophic lateral sclerosis (ALS) (see Table 2); (iii) distinct etiologies including Huntington’s chorea (HD), CreutzfeldtJakob disease (CJD) and vascular dementia (see Table 3).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Lilienfeld, D.E. and Perl, D.P. (1994) Projected neurodegenerative disease mortality among minorities in the United States. Neuroepidemiology 13, 179–186.
Parkinson, J. (1897) An essay on the Shaking Palsy, Sherwood, London.
Lieberman, A., Dziatolowski, M., Kupersmith, M., et al. (1979) Dementia in Parkinson’s disease. Ann. Neurol. 6, 355–359.
Brown, R.G. and Marsden, C.D. (1984) How common is dementia in Parkinson’s disease? Lancet 1, 1262–1265.
Mayeux, R., Stern, Y., Rosenstein, R., et al. (1988) An estimate of the prevalence of dementia in idiopathic Parkinson’s disease. Arch. Neurol. 45, 260–262.
Marder, K., Ming-Xin, T., Cote, L., Stern, Y., and Mayeux, R. (1995) The frequency and associated risk factors for dementia in patients with Parkinson’s disease. Arch. Neurol. 52, 695–701.
Aarsland, D., Andersen, K., Larsen, J.P., et al. (2001) Risk of dementia in Parkinson’s disease: a community-based, prospective study. Neurology 56, 730–736.
Appell, J., Kertesz, A., and Fisman, M. (1982) A study of language functioning in Alzheimer patients. Brain Lang. 17, 73–91.
Brown, R.G. and Marsden, C.D. (1988) ‘Subcortical dementia’ : the neuropsychological evidence. Neuroscience 25, 363–387.
McHugh, P.R. and Folstein, M.F. (eds.) (1975) Psychiatric syndromes of Huntington’s chorea: a clinical and phenomenological study, in Psychiatric Aspects of Neurological Disease (Benson, D.F. and Blumer, D., eds.), Grune & Stratton, New York, pp. 267–285.
Albert, M.L., Feldman, R.G., and Willis, A.L. (1974) The ‘subcortical dementia’ of progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiatry 37, 121–130.
Albert, M. (1978) Subcortical dementia, in Alzheimer’s Disease: Senile Dementia and Related Disorders (Katzman, R., Terry, R.D., and Bick, K.L., eds.), Raven Press, New York, pp. 173–180.
Dubois, B., Pillon, B., Legault, F., Agid, Y., and Lhermitte, F. (1988) Slowing of cognitive processing in progressive supranuclear palsy. Arch. Neurol. 45, 1194–1199.
Mayeux, R., Stern, Y., and Spanton, S. (1985) Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 35, 453–461.
Kosaka, K., Yoshimura, M., Ikeda, K., and Budka, H. (1984) Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree-a new disease? Clin. Neuropathol. 3, 185–192.
Gibb, W.R.G., Esiri, M.M., and Lees, A.J. (1985) Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 110, 1131–1153.
McKeith, I.G., Galasko, D., Kosaka, K., et al. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47, 1113–1124.
del Ser, T., Hachinski, V., Merskey, H., and Munoz, D.G. (2001) Clinical and pathologic features of two groups of patients with dementia with Lewy bodies: effect of coexisting Alzheimer-type lesion load. Alzheimer Dis. Assoc. Disord. 15, 31–44.
Holmes, C., Cairns, N., Lantos, P., and Mann, A. (1999) Validity of current clinical criteria for Alzheimer’s disease, vascular dementia and dementia with Lewy bodies. Br. J. Psychiatry 174, 45–50.
Garruto, R.M., Fukatsu, R., Yanagihara, R., et al. (1984) Imaging of calcium and aluminum in neurofibrillary tanglebearing neurons in parkinsonism-dementia of Guam. Proc. Natl. Acad. Sci. USA 81, 1875–1879.
Akelaitis, A.J. (1944) Atrophy of basal ganglia in Pick’s disease. A clinicopathologic study. Arch. Neurol. Psychiatr 51, 27–34.
Kertesz, A. and Munoz, D.G. (1998) Pick’s Disease and Pick Complex, Wiley-Liss, New York.
The Lund and Manchester Groups (1994) Clinical and neuropathological criteria for frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 57, 416–418.
Kertesz, A., Hudson, L., Mackenzie, I.R.A., and Munoz, D.G. (1994) The pathology and nosology of primary progressive aphasia. Neurology 44, 2065–2072.
Frattali, C.M., Grafman, J., Patronas, N., Makhlouf, F., and Litvan, I. (2000) Language disturbances in corticobasal degeneration. Neurology 54, 990–992.
Kertesz, A., Martinez-Lage, P., Davidson, W., and Munoz, D.G. (2000) The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 55, 1368–1375.
Houlden, H., Baker, M., Morris, H.R., et al. (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56, 1702–1706.
Zhukareva, V., Vogelsberg-Ragaglia, V., Van Deerlin, V., et al. (2001) Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann. Neurol. 49, 165–175.
Grimes, D.A., Bergeron, C.B., and Lang, A.E. (1999) Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration. Mov. Disord. 14, 674–680.
Rebeiz, J.J., Kolodny, E.H., and Richardson, E.P. Jr. (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch. Neurol. 18, 20–33.
Gibb, W.R.G., Luthert, P.J., and Marsden, C.D. (1989) Corticobasal degeneration. Brain 112, 1171–1192.
Riley, D.E., Lang, A.E., Lewis, M.B., et al. (1990) Cortical-basal ganglionic degeneration. Neurology 40, 1203–1212.
Rinne, J.O., Lee, M.S., Thompson, P.D., and Marsden, C.D. (1994) Corticobasal degeneration. Brain 117, 1183–1196.
Litvan, I., Agid, Y., Jankovic, J., et al. (1997) Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 46, 1–9.
Bergeron, C., Davis, A., and Lang, A.E. (1998) Corticobasal ganglionic degeneration and progressive supranuclear palsy Presenting with cognitive decline. Brain Pathol. 8, 355–365.
Schneider, J.A., Watts, R.L., Gearing, M., Brewer, R.P., and Mina, S.S. (1997) Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 48, 959–969.
Pillon, B., Blin, J., Vidailhet, M., et al. (1995) The neuropsychological pattern of corticobasal degeneration: cornparison with progressive supranuclear palsy and Alzheimer’s disease. Neurology 45, 1477–1483.
Feany, M.B., Mattiace, L.A., and Dickson, D.W. (1996) Neuropathologic overlap of progressive supranuclear palsy, Pick’s disease and corticobasal degeneration. J. Neuropathol. Exp. Neurol. 55, 53–67.
Butters, N., Tarlow, S., and Cermak, L.S. (1976) A comparison of the information processing deficits of patients with Huntington’s chorea and Korsakoff’s syndrome. Cortex 12, 134–144.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kertesz, A. (2003). The Clinical Spectrum of Dementia in Movement Disorders. In: Bédard, MA., Agid, Y., Chouinard, S., Fahn, S., Korczyn, A.D., Lespérance, P. (eds) Mental and Behavioral Dysfunction in Movement Disorders. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-326-2_17
Download citation
DOI: https://doi.org/10.1007/978-1-59259-326-2_17
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-372-5
Online ISBN: 978-1-59259-326-2
eBook Packages: Springer Book Archive